Trigeminal Neuralgia News and Research RSS Feed - Trigeminal Neuralgia News and Research

Trigeminal neuralgia (TN), also called tic douloureux, is a chronic pain condition that causes extreme, sporadic, sudden burning or shock-like face pain.  The pain seldom lasts more than a few seconds or a minute or two per episode. The intensity of pain can be physically and mentally incapacitating. TN pain is typically felt on one side of the jaw or cheek. Episodes can last for days, weeks, or months at a time and then disappear for months or years.  In the days before an episode begins, some patients may experience a tingling or numbing sensation or a somewhat constant and aching pain.  The attacks often worsen over time, with fewer and shorter pain-free periods before they recur.  The intense flashes of pain can be triggered by vibration or contact with the cheek (such as when shaving, washing the face, or applying makeup), brushing teeth, eating, drinking, talking, or being exposed to the wind.  TN occurs most often in people over age 50, but it can occur at any age, and is more common in women than in men.  There is some evidence that the disorder runs in families, perhaps because of an inherited pattern of blood vessel formation. Although sometimes debilitating, the disorder is not life-threatening.
AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into an agreement to sell its Gamma Knife and radiation therapy services business in Turkey to Euromedic Cancer Treatment Centers BV. [More]
AMS' revenues decrease 4.6% to $3,937,000 in fourth quarter 2013

AMS' revenues decrease 4.6% to $3,937,000 in fourth quarter 2013

American Shared Hospital Services, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and 2013. [More]
New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

New Gamma Knife stereotactic radiosurgery reduces severe facial pain caused by nerve disorder

Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia, or TN, a nerve disorder causing severe facial pain, were reduced in those treated with Gamma Knife stereotactic radiosurgery. [More]
LCH hosts international dental teaching symposium at Jessie Trice Community Health Center

LCH hosts international dental teaching symposium at Jessie Trice Community Health Center

Larkin Community Hospital, one of Florida's twelve statutory teaching hospitals, will host an international dental teaching symposium at Jessie Trice Community Health Center in Miami on August 22nd - August 24th. [More]
FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia. [More]
Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and the University of Florida department of neurosurgery have partnered to expand the neurosurgery program at Orlando Health with the opening of a specialized practice, UF Health Neurosurgery — Orlando Health. [More]
AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

he American Association of Neurological Surgeons and Congress of Neurological Surgeons are urging Congress to restore Medicare hospital outpatient payment rates for Cobalt-60-based stereotactic radiosurgery to those in place prior to the enactment of the American Taxpayer Relief Act. [More]
HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions. [More]
Neuros Medical honored as most promising startup

Neuros Medical honored as most promising startup

Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise. [More]
AMS announces FDA clearance of MEVION S250 Proton Therapy System

AMS announces FDA clearance of MEVION S250 Proton Therapy System

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement from Mevion Medical Systems, Inc. regarding Mevion Medical Systems' receipt of FDA 510(k) clearance for its MEVION S250 Proton Therapy System. [More]
Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the Phase II proof of concept study for CNV1014802 for the treatment of pain associated with trigeminal neuralgia (TN) has started. [More]
American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

American Shared Hospital Services fourth quarter revenues increase 8.4% to $4,500,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and 2011. [More]
American Shared Hospital Services third quarter revenue increases to $9,148,000

American Shared Hospital Services third quarter revenue increases to $9,148,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the third quarter and first nine months of 2011. [More]

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company. [More]

Laser Med Center receives FDA approval for device to treat Trigeminal Neuralgia

Laser Med Center, which specializes in treating Trigeminal Neuralgia, has received an FDA approval for its revolutionary laser device. This is a non-invasive alternative to surgery, which treats pain through nerve tissue regeneration. [More]
Microvascular compression syndrome may cause Parkinson's

Microvascular compression syndrome may cause Parkinson's

A potentially treatable blood vessel abnormality in the brain may be the cause of Parkinson's Disease in some patients, according to a study published today in the journal Neurology International by a team of leading physicians and neuroscientists at Pittsburgh's Allegheny General Hospital. [More]
American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter and first half of 2011. [More]
Vampire bats can smell blood-rich prey: Study

Vampire bats can smell blood-rich prey: Study

In the labs of University of California, San Francisco and from the wilds of Venezuela scientists have discovered how vampire bats have evolved over the years with a unique weapon that enables them to zero in for a ravenous feed on the warmest blood vessels of their prey. [More]
Lovelace Medical Center upgrades to Gamma Knife Perfexion system

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a contract to supply a Gamma Knife® Perfexion™ system to Lovelace Medical Center in Albuquerque, New Mexico. [More]
Pitt, UPCI researchers' cancer studies presented at AACR meeting

Pitt, UPCI researchers' cancer studies presented at AACR meeting

How do certain multiple myeloma treatment drugs cause complications? How does the immune system become dysfunctional due to cancer? How safe is a vaccine that could prevent development of precancerous colon polyps? Those are among the many questions that will be answered by researchers from the University of Pittsburgh Cancer Institute and the University of Pittsburgh School of Medicine during the American Association for Cancer Research 102nd Annual Meeting 2011, April 2 to 6, in Orlando, Fla. [More]